StonvexLoading…
StonvexStonvexStonvexCore line items from U's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.85B | $1.81B | $2.19B | $1.39B |
Operating Income | $-479.05M | $-755.15M | $-832.79M | $-882.21M |
Net Income | $-402.76M | $-664.11M | $-822.01M | $-921.06M |
EPS (Diluted) | $-0.96 | $-1.68 | $-2.16 | $-2.96 |
Total Assets | $6.84B | $6.74B | $7.24B | $7.83B |
Total Liabilities | $3.34B | $3.31B | $3.83B | $4.08B |
Cash & Equivalents | $2.06B | $1.52B | $1.59B | $1.49B |
Free Cash Flow OCF − CapEx | $403.93M | $286.00M | $178.78M | $-116.57M |
Shares Outstanding | 432.86M | 409.39M | 384.87M | 374.24M |